To report the 3-year results of a prospective, single arm, multicenter, international clinical study with the second generation of the temporary implantable nitinol device (iTIND; Medi-Tate Ltd®, Israel) on men suffering lower urinary tract symptoms (LUTS) secondary to benign prostatic obstruction (BPO).

3-Year results following treatment with the second generation of the temporary implantable nitinol device in men with LUTS secondary to benign prostatic obstruction

Amparore, Daniele
;
Fiori, Cristian;De Cillis, Sabrina;Porpiglia, Francesco
2021

Abstract

To report the 3-year results of a prospective, single arm, multicenter, international clinical study with the second generation of the temporary implantable nitinol device (iTIND; Medi-Tate Ltd®, Israel) on men suffering lower urinary tract symptoms (LUTS) secondary to benign prostatic obstruction (BPO).
24
2
349
357
Aged; Aged, 80 and over; Alloys; Follow-Up Studies; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prognosis; Prospective Studies; Prostatic Hyperplasia; Prostatic Neoplasms; Prostheses and Implants; Quality of Life
Amparore, Daniele; Fiori, Cristian; Valerio, Massimo; Schulman, Claude; Giannakis, Ioannis; De Cillis, Sabrina; Kadner, Gregor; Porpiglia, Francesco
File in questo prodotto:
File Dimensione Formato  
s41391-020-00281-5.pdf

Accesso aperto

Dimensione 798.75 kB
Formato Adobe PDF
798.75 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1870381
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 18
  • ???jsp.display-item.citation.isi??? ND
social impact